Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00139) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Amprenavir
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Approved/Marketed Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=65016"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Cytochrome P450 3A4 (CYP3A4) | DME Info | Homo sapiens | [1] | |||
| Xenobiotics-DME Activity Data | ||||||
| Xenobiotics-DME Activity Data | Cytochrome P450 3A4 (CYP3A4) | DME Info | IC50 = 1 microM | [1] | ||
| References | ||||||
| 1 | Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.